US Broker Ratings

Stryker Corporation (SYK) Stock Analysis: Investor Outlook Reveals 12.22% Upside Potential

Stryker Corporation (NYSE: SYK), a heavyweight in the medical devices industry with a market capitalization of $143.53 billion, stands out as a compelling investment opportunity in..

ResMed Inc. (RMD) Stock Analysis: Exploring Growth Prospects in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, ResMed Inc. (NYSE: RMD) presents a compelling case. Positioned at the intersection of medical devices and cloud-based software,..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 10.69% Potential Upside with Strong Buy Ratings

Tenet Healthcare Corporation (NYSE: THC) stands out in the healthcare sector, not only for its comprehensive services but also for the investment potential it offers. With..

Agilent Technologies, Inc. (A) Investor Outlook: Analyzing a Potential 18.40% Upside in the Diagnostics Sector

Agilent Technologies, Inc. (NYSE: A) stands as a formidable entity within the healthcare sector, operating primarily in the diagnostics and research industry. With a market capitalization..

Baxter International Inc. (BAX): Investor Outlook with a 27.85% Upside Potential

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, offers investors a unique opportunity to delve into the medical instruments and supplies industry. With..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Challenges with Potential 19.88% Upside

Illumina, Inc. (NASDAQ: ILMN), a leader in the healthcare sector specializing in diagnostics and research, stands at a critical juncture. With a market capitalization of $14.32..

Quest Diagnostics (DGX) Investor Outlook: A Resilient Performer in Diagnostics with a 2.50% Upside

In the ever-evolving landscape of healthcare, Quest Diagnostics Incorporated (NYSE: DGX) remains a formidable player, solidifying its standing in the diagnostics and research industry. With a..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Evaluating a 17.85% Potential Upside in the Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the medical devices industry, continues to be a focal point for investors seeking opportunities in the healthcare..

Solventum Corporation (SOLV) Stock Analysis: Exploring the 11.68% Potential Upside

Solventum Corporation (SOLV), a healthcare giant specializing in medical instruments and supplies, stands out as a compelling consideration for investors eyeing the medical sector. With a..

Novo Nordisk A/S (NVO) Stock Analysis: Exploring a 23.76% Potential Upside for Investors

Novo Nordisk A/S (NVO), a titan in the healthcare sector, has long been a cornerstone for investors seeking stability and growth within the pharmaceutical industry. Headquartered..

GSK plc (GSK) Stock Analysis: Unveiling a Robust 9.10% Upside Potential

GSK plc (NYSE: GSK), a titan in the healthcare sector, continues to capture investor attention with its dynamic role in the drug manufacturing industry. Based in..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a Promising 31.42% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR) is a significant player in the healthcare sector, specifically in the niche of specialty and generic drug manufacturing. The company, headquartered..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Navigating a 13.38% Potential Upside Amid Biotech Innovation

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, with a market capitalization of $113.21 billion. Headquartered in Boston, Massachusetts, Vertex..

Merck & Company, Inc. (MRK) Stock Analysis: Unveiling a 28.75% Potential Upside in the Healthcare Giant

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, presents itself as an intriguing prospect for investors seeking stability and growth in the..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with 40% Upside Potential

argenx SE (NASDAQ: ARGX), the Netherlands-based biotechnology innovator, is capturing the attention of the healthcare investment community with its impressive market cap of $33.16 billion. As..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating a Biotech Giant’s Growth Trajectory and 4.12% Upside Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a prominent player in the biotechnology sector, has long been on the radar of investors seeking exposure to cutting-edge medical innovations...

Cencora, Inc. (COR) Investor Outlook: A Robust 9.48% Potential Upside in the Healthcare Sector

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, is making significant waves in the healthcare sector. With a substantial market capitalization of $56.92 billion, this..

AstraZeneca PLC (AZN) Stock Analysis: Unpacking a 20% Potential Upside for Investors

AstraZeneca PLC (NASDAQ: AZN), a biopharmaceutical titan headquartered in Cambridge, the United Kingdom, is currently drawing significant attention from investors who are keenly observing its promising..

Bristol-Myers Squibb Company (BMY) Stock Analysis: Unveiling a 21.84% Upside Potential and Robust Dividend

Bristol-Myers Squibb Company (NYSE: BMY), a key player in the healthcare sector and a titan in the drug manufacturing industry, boasts a market capitalization of approximately..

IQVIA Holdings, Inc. (IQV) Investor Outlook: Exploring a 22.91% Potential Upside in Healthcare Analytics

IQVIA Holdings, Inc. (NYSE: IQV) stands as a formidable player in the healthcare sector, particularly within the Diagnostics & Research industry. Headquartered in Durham, North Carolina,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds